| 1 |
Sun D, Schaff HV, Nishimura RA, et al. Transapical septal myectomy for hypertrophic cardiomyopathy with midventricular obstruction [J]. Ann Thorac Surg, 2021, 111(3): 836-844.
|
| 2 |
Yan LR, Zhao SH, Wang HY, et al. Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy [J]. J Cardiovasc Med (Hagerstown), 2015, 16(11): 751-760.
|
| 3 |
Tang Y, Song Y, Duan F, et al. Extended myectomy for hypertrophic obstructive cardiomyopathy patients with midventricular obstruction [J]. Eur J Cardiothorac Surg, 2018, 54(5): 875-883.
|
| 4 |
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2014, 35(39): 2733-2779.
|
| 5 |
Inagaki N, Hayashi T, Takei Y, et al. Clinical and genetic backgrounds of hypertrophic cardiomyopathy with mid-ventricular obstruction [J]. J Hum Genet, 2018, 63(12): 1273-1276.
|
| 6 |
Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy [J]. Circ Res, 2017, 121(7): 749-770.
|
| 7 |
Cahill TJ, Ashrafian H, Watkins H. Genetic cardiomyopathies causing heart failure [J]. Circ Res, 2013, 113(6): 660-675.
|
| 8 |
Minami Y, Kajimoto K, Terajima Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2011, 57(23): 2346-2355.
|
| 9 |
Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy [J]. Circulation, 2008, 118(15): 1541-1549.
|
| 10 |
Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling [J]. Lancet, 2006, 367(9507): 356-367.
|
| 11 |
刘丽文. 超声心动图在肥厚型心肌病临床管理中的应用现状与思考 [J/OL]. 中华医学超声杂志(电子版), 2020, 17(5): 385-390.
|
| 12 |
Rigopoulos AG, Seggewiss H. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy [J]. Circ J, 2011, 75(1): 28-37.
|
| 13 |
刘丽文, 王静. 肥厚型心肌病超声心动图检查规范专家共识 [J/OL]. 中华医学超声杂志(电子版), 2020, 17(5): 394-408.
|
| 14 |
Parato VM, Scarano M, Cicchitti V, et al. Involvement of the right ventricle in hypertrophic cardiomyopathy and occurrence of right bundle branch block [J]. Int J Cardiol, 2016, 202: 75-76.
|
| 15 |
Malik R, Maron MS, Rastegar H, et al. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction [J]. Echocardiography, 2014, 31(5): 682-685.
|
| 16 |
Parato VM, Antoncecchi V, Sozzi F, et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy [J]. Cardiovasc Ultrasound, 2016, 14(1): 30.
|
| 17 |
Sivanandam A, Ananthasubramaniam K. Midventricular hypertrophic cardiomyopathy with apical aneurysm: potential for underdiagnosis and value of multimodality imaging [J]. Case Rep Cardiol, 2016, 2016: 9717948.
|
| 18 |
周围. 不同亚型肥厚型心肌病心脏磁共振心肌应变和延迟强化特征的对比研究 [D]. 江西: 南昌大学.
|
| 19 |
Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2011, 124(24): e783- e831.
|
| 20 |
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. J Thorac Cardiovasc Surg, 2021, 162(1): e23-e106.
|
| 21 |
中国医师协会心力衰竭专业委员会, 中华心力衰竭和心肌病杂志编辑委员会. 中国肥厚型心肌病管理指南2017 [J]. 中华心力衰竭和心肌病杂志(中英文), 2017, 1(2): 65-86.
|
| 22 |
Cui L, Tse G, Zhao Z, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy [J]. Ann Noninvasive Electrocardiol, 2019, 24(5): e12638.
|
| 23 |
Spirito P, Rossi J, Maron BJ. Alcohol septal ablation: in which patients and why? [J]. Ann Cardiothorac Surg, 2017, 6(4): 369-375.
|
| 24 |
Kunkala MR, Schaff HV, Nishimura RA, et al. Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy [J]. Ann Thorac Surg, 2013, 96(2): 564-570.
|
| 25 |
Nguyen A, Schaff HV. Surgical myectomy: subaortic, midventricular, and apical [J]. Cardiol Clin, 2019, 37(1): 95-104.
|
| 26 |
Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population [J]. Circulation, 2000, 102(8): 858-864.
|
| 27 |
Yan L, Wang Z, Xu Z, et al. Two hundred eight patients with apical hypertrophic cardiomyopathy in china: clinical feature, prognosis, and comparison of pure and mixed forms [J]. Clin Cardiol, 2012, 35(2): 101-106.
|
| 28 |
Efthimiadis GK, Pagourelias ED, Parcharidou D, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction [J]. Circ J, 2013, 77: 2366-2374.
|